Ken Congdon

ARTICLES BY KEN CONGDON

• The California Drought’s Impact On Pharma

  10/22/2015

  Drought conditions are making it increasingly difficult for pharmaceutical manufacturers to secure the proper wastewater permits in The Golden State.

• The Evolution Of A Cold Chain Conference

  9/28/2015

  The Cold Chain Global Forum has grown from a niche conference to the life science industry's leading temperature-controlled event.

• Performance-Based Pricing Poised To Hit Pharma

  9/25/2015

  Many call for transparency to combat high drug costs, but outcomes-based pricing is a more realistic solution.  

• FBI Insights On Counterfeit Drug Prevention

  9/18/2015

  A former FBI agent shares his tips for protecting your products from counterfeit activity.

• Key Trends, Cross Pollination Drive Pharma EXPO

  9/15/2015

  Pharma EXPO is right around the corner. Discover the key industry trends that directly influenced this year’s conference program and how the event provides a unique opportunity for pharmaceutical professionals to learn from other industries.

• Pharma Needs A Medication Adherence Game Plan

  9/14/2015

  Medication nonadherence is a disturbing trend that has a negative effect on patient wellness, hospital costs, and pharmaceutical manufacturer revenue. Drugmakers need to drive improvements in this area and big data, sensor technology, and a new approach to marketing can help.

• Keeping Current With The Cold Chain

  9/11/2015

  Meeting the temperature-control needs today’s life science products requires manufacturers to balance regulatory compliance with quality and cost. Discover how the 13^th Annual Cold Chain Global Forum can provide you with the insight necessary to succeed.

• 3 Can’t-Miss Sessions At Pharma EXPO 2015

  9/3/2015

  Pharma EXPO 2015 offers several educational opportunities to choose from, but these three sessions alone could be worth the trip to Vegas.

• Shaping The Emerging Biosimilars Landscape

  8/26/2015

  The emergence of biosimilars in the U.S. will  undoubtedly have a marked impact on the pharmaceutical industry, but the market is young and malleable. Pharmaceutical manufacturers currently have a unique opportunity to shape perceptions and use of biosimilars among healthcare providers and their patients.

• “Perfect Storm” Demands A Pharma Supply Chain Overhaul

  8/10/2015

  According to some pharmaceutical industry experts, a pending explosion in biologics coupled with universally inflexible supply chains are creating a perfect storm that demands and overhaul in order to meet demand. Here’s what you can do today.